MktsMarkets

Abeona Therapeutics Inc.
NASDAQ: ABEOKey statistics
ABEO News
Stories mentioning ABEO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 8,720 | 400.00 | ||||||
| Cost of Goods Sold | 2,696 | 488.00 | ||||||
| Gross Profit | 6,024 | (488.00) | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Operating Expenses | ||||||||
| Research & Development | 9,555 | 6,712 | 4,216 | 5,943 | 9,941 | 8,994 | 8,941 | 9,218 |
| Sales General & Admin | 19,502 | 18,782 | 19,314 | 17,149 | 9,786 | 6,404 | 8,646 | |
| Total Operating Expenses | 23,192 | 19,727 | 16,672 | 15,345 | 17,864 | |||
| Operating Income (Loss) | (23,033) | (22,911) | (24,018) | (22,792) | (19,727) | (16,672) | (15,345) | (17,864) |
| Interest Income | ||||||||
| Interest Expense | 830.00 | 884.00 | 901.00 | 957.00 | 998.00 | 1,082 | 1,102 | 1,072 |
| Other Expense | ||||||||
| Pretax Income | (17,073) | (20,675) | (20,358) | 124,345 | (12,029) | (30,269) | 7,406 | |
| Tax Provision | 2.00 | (15,197) | 15,512 | |||||
| Net Income (Loss) | (17,075) | (20,460) | (5,161) | 108,833 | (12,029) | (9,293) | (30,269) | 7,406 |
| Earnings Per Share (Basic) | (0.30) | (0.39) | (0.10) | 2.07 | (0.24) | (0.23) | (0.63) | 0.19 |
| Earnings Per Share (Diluted) | (0.30) | (0.31) | (0.10) | 1.71 | (0.24) | (0.23) | (0.63) | (0.26) |
| Weighted Average Shares Outstanding (Basic) | 56,621 | 52,953 | 54,243 | 52,525 | 49,779 | 41,048 | 48,082 | 40,010 |
| Weighted Average Shares Outstanding (Diluted) | 56,621 | 66,136 | 54,243 | 66,641 | 49,779 | 41,048 | 48,082 | 51,227 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ABEO
Abeona Therapeutics Inc. (NASDAQ: ABEO) is a stock listed on the Nasdaq Stock Market under the ticker symbol ABEO. It last traded at $2.42 (Nov 13, 2026, 4:00 PM ET), up 5.7% on the day. That gives Abeona Therapeutics a market capitalisation of $126.6M.
Over the past 52 weeks ABEO has traded between $2.22 and $7.65.
Revenue for the quarter ended Mar 31, 2026 was $8.7M; a net loss of $17.1M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $8.7M | -$17.1M | -195.8% |
| Dec 31, 2025 | — | -$20.5M | — |
| Sep 30, 2025 | — | -$5.2M | — |
| Jun 30, 2025 | $400.0K | $108.8M | 27208.3% |
From Abeona Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…